Who is sponsoring NCT03664388?

NCT03664388 is sponsored by Hospital Álvaro Cunqueiro.

What drugs are being tested in NCT03664388?

Interventions in NCT03664388: Dual antiplatelet therapy with ticagrelor/prasuglre.

What condition does NCT03664388 study?

NCT03664388 studies Acute Coronary Syndrome.

Is NCT03664388 still recruiting?

NCT03664388 is currently status unknown. Last updated 10 September 2018.

Last reviewed 2018-09-10 · How we verify

NCT03664388: CardioCHUVI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Registry of Acute Coronary Syndrome From University Hospital of Vigo

Status unknown Last updated 10 September 2018

What this trial tests

trial testing Dual antiplatelet therapy with ticagrelor/prasuglre in Acute Coronary Syndrome in 8,000 participants. Status unknown.

Timeline

1 February 2016

Primary endpoint
6 September 2018

1 February 2020

Quick facts

Lead sponsor	Hospital Álvaro Cunqueiro
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	8,000
Start date	1 February 2016
Primary completion	6 September 2018
Estimated completion	1 February 2020
Sites	1 location across Spain

Drugs / interventions tested

Dual antiplatelet therapy with ticagrelor/prasuglre — full drug profile →

Conditions studied

Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →

Sponsor

Hospital Álvaro Cunqueiro

Who can join

Eligibility, any sex, with Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

CardoCHUVI registry was aim to study ischemic and bleeding complication after an acute coronary syndrome (ACS), both in-hospital and follow-up events.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07230847 — A Study Evaluating the Vascular Healing and Neointimal Transformation at 1 Month After Implantation of BioFreedom™ Drug- · NA · recruiting
NCT07032389 — A Polypill for Acute Coronary Syndrome · Phase 2 · recruiting
NCT07102628 — Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronar · Phase 3 · recruiting
NCT06416813 — Preventive Intervention Value of DCB in Vulnerable Coronary Atherosclerotic Plaques · NA · active not recruiting

Other Hospital Álvaro Cunqueiro trials

Trials by the same sponsor.

NCT06567522 — Comparative Assessment of Effectiveness and Safety of L-ESPB Versus Absence of Locoregional Block in Hip Surgery · Phase 4 · recruiting
NCT04364516 — Retrospective Observational Registry of Patients With Atrial Fibrillation From Vigo´s Health Area · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03664388 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospital Álvaro Cunqueiro
Last refreshed: 10 September 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03664388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing